Gastroenterology Research and Practice / 2015 / Article / Tab 1

Review Article

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors

Table 1

Clinical and laboratory findings in 64 patients with hypomagnesemia (<0.75 mmol/L) while being on long-term management with a proton-pump inhibitor. Numerical data are presented as median and interquartile range (which extends from the value at centile 25 to that at centile 75 and includes half of the data points) and categorical data as relative frequency.

Age, years66 [59–73]
Gender, ♂/♀30/34
Circulating magnesium level, mmol/L0.24 [0.15–0.30]
Duration of treatment with proton-pump inhibitor, years4 [3–10]
Urinary magnesium excretion, low/normal42/0
Circulating calcium level, low/normal58/2
Parathyroid hormone level, low-normal/high42/2
Circulating potassium level, low/normal27/4

Assessed exclusively in subjects with total calcium level <2.20 mmol/L. <3.5 mmol/L.